{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T16:45:13Z","timestamp":1791477913974,"version":"4.3.4"},"reference-count":170,"publisher":"Elsevier BV","issue":"48","license":[{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,21]],"date-time":"2020-08-21T00:00:00Z","timestamp":1597968000000},"content-version":"vor","delay-in-days":659,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["jbc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Biological Chemistry"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1074\/jbc.tm118.003336","type":"journal-article","created":{"date-parts":[[2018,11,7]],"date-time":"2018-11-07T20:35:19Z","timestamp":1541622919000},"page":"18757-18769","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":147,"title":["Polyamine synthesis as a target of MYC oncogenes"],"prefix":"10.1016","volume":"293","author":[{"given":"Andr\u00e9 S.","family":"Bachmann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6386-8187","authenticated-orcid":false,"given":"Dirk","family":"Geerts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1074\/jbc.TM118.003336_bib1","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1111\/j.1469-8137.1994.tb02953.x","article-title":"Stay-green genotypes of Phaseolus vulgaris L.: chloroplast proteins and chlorophyll catabolites during foliar senescence","volume":"126","author":"Bachmann","year":"1994","journal-title":"New Phytol"},{"key":"10.1074\/jbc.TM118.003336_bib2","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1006\/pmpp.1998.0183","article-title":"Inhibition of ornithine decarboxylase activity by phaseolotoxin: implications for symptom production in halo blight of French bean","volume":"53","author":"Bachmann","year":"1998","journal-title":"Physiol. Mol. Plant Pathol"},{"key":"10.1074\/jbc.TM118.003336_bib3","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.pmpp.2003.09.005","article-title":"Characterization of ornithine decarboxylase from Pseudomonas syringae pv. phaseolicola and its inhibition by phaseolotoxin","volume":"63","author":"Bachmann","year":"2003","journal-title":"Physiol. Mol. Plant Pathol"},{"key":"10.1074\/jbc.TM118.003336_bib4","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.leukres.2003.07.002","article-title":"Inhibitory effects of phaseolotoxin on proliferation of leukemia cells HL-60, K-562 and L1210 and pancreatic cells RIN-m5F","volume":"28","author":"Bachmann","year":"2004","journal-title":"Leuk. Res"},{"key":"10.1074\/jbc.TM118.003336_bib5","doi-asserted-by":"crossref","first-page":"2551","DOI":"10.1021\/ja00476a050","article-title":"Catalytic irreversible inhibition of mammalian ornithine decarboxylase (E.C. 4.1.1.17) by substrate and product analogs","volume":"100","author":"Metcalf","year":"1978","journal-title":"J. Am. Chem. Soc"},{"key":"10.1074\/jbc.TM118.003336_bib6","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/S0140-6736(09)61117-X","article-title":"Nifurtimox-eflornithine combination therapy for second-stage African Trypanosoma brucei gambiense trypanosomiasis: a multicentre, randomised, phase III, non-inferiority trial","volume":"374","author":"Priotto","year":"2009","journal-title":"Lancet"},{"key":"10.1074\/jbc.TM118.003336_bib7","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1158\/1940-6207.CAPR-08-0042","article-title":"Difluoromethylornithine plus sulindac for the prevention of sporadic colorectal adenomas: a randomized placebo-controlled, double-blind trial","volume":"1","author":"Meyskens","year":"2008","journal-title":"Cancer Prev. Res"},{"key":"10.1074\/jbc.TM118.003336_bib8","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0127246","article-title":"A Phase I trial of DFMO targeting polyamine addiction in patients with relapsed\/refractory neuroblastoma","volume":"10","author":"Saulnier Sholler","year":"2015","journal-title":"PLoS ONE"},{"key":"10.1074\/jbc.TM118.003336_bib9","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-32659-w","article-title":"Maintenance DFMO increases survival in high risk neuroblastoma","volume":"8","author":"Sholler","year":"2018","journal-title":"Sci. Rep"},{"key":"10.1074\/jbc.TM118.003336_bib10","first-page":"371","article-title":"The role of polyamines in human cancer: prospects for drug combination therapies","volume":"63","author":"Bachmann","year":"2004","journal-title":"Hawaii Med. J"},{"key":"10.1074\/jbc.TM118.003336_bib11","doi-asserted-by":"crossref","first-page":"5606","DOI":"10.1038\/sj.onc.1208808","article-title":"Key role for p27Kip1, retinoblastoma protein Rb, and MYCN in polyamine inhibitor-induced G1 cell cycle arrest in MYCN-amplified human neuroblastoma cells","volume":"24","author":"Wallick","year":"2005","journal-title":"Oncogene"},{"key":"10.1074\/jbc.TM118.003336_bib12","first-page":"445","article-title":"c-myc transactivates the ornithine decarboxylase gene","volume":"182","author":"Bello-Fernandez","year":"1992","journal-title":"Curr. Top. Microbiol. Immunol"},{"key":"10.1074\/jbc.TM118.003336_bib13","doi-asserted-by":"crossref","first-page":"7804","DOI":"10.1073\/pnas.90.16.7804","article-title":"The ornithine decarboxylase gene is a transcriptional target of c-Myc","volume":"90","author":"Bello-Fernandez","year":"1993","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"10.1074\/jbc.TM118.003336_bib14","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1038\/sj.onc.1201939","article-title":"Involvement of Myc targets in c-myc and N-myc induced human tumors","volume":"17","author":"Ben-Yosef","year":"1998","journal-title":"Oncogene"},{"key":"10.1074\/jbc.TM118.003336_bib15","series-title":"Pediatric Cancer, Neuroblastoma: Diagnosis, Therapy, and Prognosis","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/978-94-007-2418-1_9","author":"Bachmann","year":"2012"},{"key":"10.1074\/jbc.TM118.003336_bib16","series-title":"Polyamine Drug Discovery","first-page":"257","author":"Bachmann","year":"2012"},{"key":"10.1074\/jbc.TM118.003336_bib17","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1007\/s13402-014-0201-9","article-title":"Deoxyhypusine synthase (DHPS) inhibitor GC7 induces p21\/Rb-mediated inhibition of tumor cell growth and DHPS expression correlates with poor prognosis in neuroblastoma patients","volume":"37","author":"Bandino","year":"2014","journal-title":"Cell Oncol"},{"key":"10.1074\/jbc.TM118.003336_bib18","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1002\/ijc.25074","article-title":"The polyamine metabolism genes ornithine decarboxylase and antizyme 2 predict aggressive behavior in neuroblastomas with and without MYCN amplification","volume":"126","author":"Geerts","year":"2010","journal-title":"Int. J. Cancer"},{"key":"10.1074\/jbc.TM118.003336_bib19","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1158\/1535-7163.MCT-08-1217","article-title":"Inhibition of S-adenosylmethionine decarboxylase by inhibitor SAM486A connects polyamine metabolism with p53-Mdm2-Akt\/protein kinase B regulation and apoptosis in neuroblastoma","volume":"8","author":"Koomoa","year":"2009","journal-title":"Mol. Cancer Ther"},{"key":"10.1074\/jbc.TM118.003336_bib20","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.3892\/ijo.2013.1835","article-title":"DFMO\/eflornithine inhibits migration and invasion downstream of MYCN and involves p27Kip1 activity in neuroblastoma","volume":"42","author":"Koomoa","year":"2013","journal-title":"Int. J. Oncol"},{"key":"10.1074\/jbc.TM118.003336_bib21","doi-asserted-by":"crossref","first-page":"9825","DOI":"10.1158\/0008-5472.CAN-08-1865","article-title":"Ornithine decarboxylase inhibition by \u03b1-difluoromethylornithine activates opposing signaling pathways via phosphorylation of both Akt\/protein kinase B and p27Kip1 in neuroblastoma","volume":"68","author":"Koomoa","year":"2008","journal-title":"Cancer Res"},{"key":"10.1074\/jbc.TM118.003336_bib22","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.jmb.2013.09.037","article-title":"Novel interaction of ornithine decarboxylase with sepiapterin reductase regulates neuroblastoma cell proliferation","volume":"426","author":"Lange","year":"2014","journal-title":"J. Mol. Biol"},{"key":"10.1074\/jbc.TM118.003336_bib23","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1002\/ijc.28139","article-title":"AMXT-1501, a novel polyamine transport inhibitor, synergizes with DFMO in inhibiting neuroblastoma cell proliferation by targeting both ornithine decarboxylase and polyamine transport","volume":"133","author":"Samal","year":"2013","journal-title":"Int. J. Cancer"},{"key":"10.1074\/jbc.TM118.003336_bib24","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1042\/BCJ20170597","article-title":"Synergistic drug combination GC7\/DFMO suppresses hypusine\/spermidine-dependent eIF5A activation and induces apoptotic cell death in neuroblastoma","volume":"475","author":"Schultz","year":"2018","journal-title":"Biochem. J"},{"key":"10.1074\/jbc.TM118.003336_bib25","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1186\/s12885-015-1447-y","article-title":"Effect of sulfasalazine on human neuroblastoma: analysis of sepiapterin reductase (SPR) as a new therapeutic target","volume":"15","author":"Yco","year":"2015","journal-title":"BMC Cancer"},{"key":"10.1074\/jbc.TM118.003336_bib26","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1158\/2159-8290.CD-17-0273","article-title":"The expanding world of N-MYC-driven tumors","volume":"8","author":"Rickman","year":"2018","journal-title":"Cancer Discov"},{"key":"10.1074\/jbc.TM118.003336_bib27","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0092-8674(00)81683-9","article-title":"The hallmarks of cancer","volume":"100","author":"Hanahan","year":"2000","journal-title":"Cell"},{"key":"10.1074\/jbc.TM118.003336_bib28","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"10.1074\/jbc.TM118.003336_bib29","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.semcancer.2006.07.014","article-title":"The c-Myc target gene network","volume":"16","author":"Dang","year":"2006","journal-title":"Semin. Cancer Biol"},{"key":"10.1074\/jbc.TM118.003336_bib30","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/s11684-018-0650-z","article-title":"The MYC transcription factor network: balancing metabolism, proliferation and oncogenesis","volume":"12","author":"Carroll","year":"2018","journal-title":"Front. Med"},{"key":"10.1074\/jbc.TM118.003336_bib31","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1002\/bies.201500134","article-title":"Targeting MYC in cancer therapy: RNA processing offers new opportunities","volume":"38","author":"Koh","year":"2016","journal-title":"Bioessays"},{"key":"10.1074\/jbc.TM118.003336_bib32","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1038\/nrc2231","article-title":"Reflecting on 25 years with MYC","volume":"8","author":"Meyer","year":"2008","journal-title":"Nat. Rev. Cancer"},{"key":"10.1074\/jbc.TM118.003336_bib33","doi-asserted-by":"crossref","first-page":"3409","DOI":"10.15252\/embj.201796438","article-title":"MYC and tumor metabolism: chicken and egg","volume":"36","author":"Dejure","year":"2017","journal-title":"EMBO J"},{"key":"10.1074\/jbc.TM118.003336_bib34","doi-asserted-by":"crossref","first-page":"174","DOI":"10.3389\/fonc.2012.00174","article-title":"MYCN: from oncoprotein to tumor-associated antigen","volume":"2","author":"Pistoia","year":"2012","journal-title":"Front. Oncol"},{"key":"10.1074\/jbc.TM118.003336_bib35","doi-asserted-by":"crossref","DOI":"10.3390\/genes8060151","article-title":"MYC deregulation in primary human cancers","volume":"8","author":"Kalkat","year":"2017","journal-title":"Genes (Basel)"},{"key":"10.1074\/jbc.TM118.003336_bib36","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.cels.2018.03.003","article-title":"Pan-cancer alterations of the MYC oncogene and its proximal network across the Cancer Genome Atlas","volume":"6","author":"Schaub","year":"2018","journal-title":"Cell Syst"},{"key":"10.1074\/jbc.TM118.003336_bib37","first-page":"457","article-title":"MYC deregulation in lymphoid tumors: molecular mechanisms, clinical consequences and therapeutic implications","volume":"1846","author":"Sewastianik","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1074\/jbc.TM118.003336_bib38","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1016\/j.cell.2014.10.024","article-title":"CDK7 inhibition suppresses super-enhancer-linked oncogenic transcription in MYCN-driven cancer","volume":"159","author":"Chipumuro","year":"2014","journal-title":"Cell"},{"key":"10.1074\/jbc.TM118.003336_bib39","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1038\/nm.3665","article-title":"A NOTCH1-driven MYC enhancer promotes T cell development, transformation and acute lymphoblastic leukemia","volume":"20","author":"Herranz","year":"2014","journal-title":"Nat. Med"},{"key":"10.1074\/jbc.TM118.003336_bib40","doi-asserted-by":"crossref","first-page":"E113","DOI":"10.3390\/genes8040113","article-title":"The MYCN protein in health and disease","volume":"8","author":"Ruiz-P\u00e9rez","year":"2017","journal-title":"Genes (Basel)"},{"key":"10.1074\/jbc.TM118.003336_bib41","article-title":"Structure-based inhibitor design for the intrinsically disordered protein c-Myc","volume":"6","author":"Yu","year":"2016","journal-title":"Sci. Rep"},{"key":"10.1074\/jbc.TM118.003336_bib42","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1038\/s41392-018-0008-7","article-title":"Targeting oncogenic Myc as a strategy for cancer treatment","volume":"3","author":"Chen","year":"2018","journal-title":"Signal Transduct. Target Ther"},{"key":"10.1074\/jbc.TM118.003336_bib43","doi-asserted-by":"crossref","first-page":"E114","DOI":"10.3390\/genes8040114","article-title":"Targeting MYC dependence by metabolic inhibitors in cancer","volume":"8","author":"Sabnis","year":"2017","journal-title":"Genes (Basel)"},{"key":"10.1074\/jbc.TM118.003336_bib44","doi-asserted-by":"crossref","first-page":"5355","DOI":"10.1093\/nar\/gky385","article-title":"Cell penetrating thiazole peptides inhibit c-MYC expression via site-specific targeting of c-MYC G-quadruplex","volume":"46","author":"Dutta","year":"2018","journal-title":"Nucleic Acids Res"},{"key":"10.1074\/jbc.TM118.003336_bib45","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1158\/1535-7163.MCT-17-1209","article-title":"APTO-253 stabilizes G-quadruplex DNA, inhibits MYC expression, and induces DNA damage in acute myeloid leukemia cells","volume":"17","author":"Local","year":"2018","journal-title":"Mol. Cancer Ther"},{"key":"10.1074\/jbc.TM118.003336_bib46","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1158\/2159-8290.CD-12-0418","article-title":"Targeting MYCN in neuroblastoma by BET bromodomain inhibition","volume":"3","author":"Puissant","year":"2013","journal-title":"Cancer Discov"},{"key":"10.1074\/jbc.TM118.003336_bib47","doi-asserted-by":"crossref","first-page":"17698","DOI":"10.18632\/oncotarget.4131","article-title":"BET inhibitor OTX015 targets BRD2 and BRD4 and decreases c-MYC in acute leukemia cells","volume":"6","author":"Coud\u00e9","year":"2015","journal-title":"Oncotarget"},{"key":"10.1074\/jbc.TM118.003336_bib48","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1038\/leu.2016.355","article-title":"Preclinical activity of CPI-0610, a novel small-molecule bromodomain and extra-terminal protein inhibitor in the therapy of multiple myeloma","volume":"31","author":"Siu","year":"2017","journal-title":"Leukemia"},{"key":"10.1074\/jbc.TM118.003336_bib49","doi-asserted-by":"crossref","first-page":"3497","DOI":"10.1073\/pnas.1702663114","article-title":"Small molecule selectively suppresses MYC transcription in cancer cells","volume":"114","author":"Bouvard","year":"2017","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"10.1074\/jbc.TM118.003336_bib50","article-title":"Multiple CDK inhibitor dinaciclib suppresses neuroblastoma growth via inhibiting CDK2 and CDK9 activity","volume":"6","author":"Chen","year":"2016","journal-title":"Sci. Rep"},{"key":"10.1074\/jbc.TM118.003336_bib51","doi-asserted-by":"crossref","first-page":"6677","DOI":"10.1093\/nar\/gkv641","article-title":"Chemical intervention of the NM23-H2 transcriptional programme on c-MYC via a novel small molecule","volume":"43","author":"Shan","year":"2015","journal-title":"Nucleic Acids Res"},{"key":"10.1074\/jbc.TM118.003336_bib52","doi-asserted-by":"crossref","first-page":"2260","DOI":"10.1158\/1535-7163.MCT-14-0801","article-title":"Targeting c-MYC in platinum-resistant ovarian cancer","volume":"14","author":"Reyes-Gonz\u00e1lez","year":"2015","journal-title":"Mol. Cancer Ther"},{"key":"10.1074\/jbc.TM118.003336_bib53","doi-asserted-by":"crossref","first-page":"6175","DOI":"10.1073\/pnas.90.13.6175","article-title":"Increased expression of eukaryotic translation initiation factors eIF-4E and eIF-2\u03b1 in response to growth induction by c-myc","volume":"90","author":"Rosenwald","year":"1993","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"10.1074\/jbc.TM118.003336_bib54","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1080\/15384047.2014.1002698","article-title":"Inauhzin(c) inactivates c-Myc independently of p53","volume":"16","author":"Jung","year":"2015","journal-title":"Cancer Biol. Ther"},{"key":"10.1074\/jbc.TM118.003336_bib55","doi-asserted-by":"crossref","first-page":"11988","DOI":"10.1073\/pnas.1310230110","article-title":"Myc and mTOR converge on a common node in protein synthesis control that confers synthetic lethality in Myc-driven cancers","volume":"110","author":"Pourdehnad","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"10.1074\/jbc.TM118.003336_bib56","doi-asserted-by":"crossref","first-page":"8839","DOI":"10.1158\/0008-5472.CAN-09-1970","article-title":"The role of Myc-induced protein synthesis in cancer","volume":"69","author":"Ruggero","year":"2009","journal-title":"Cancer Res"},{"key":"10.1074\/jbc.TM118.003336_bib57","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1038\/nm1042","article-title":"The translation factor eIF-4E promotes tumor formation and cooperates with c-Myc in lymphomagenesis","volume":"10","author":"Ruggero","year":"2004","journal-title":"Nat. Med"},{"key":"10.1074\/jbc.TM118.003336_bib58","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1038\/nrc.2016.27","article-title":"New frontiers in translational control of the cancer genome","volume":"16","author":"Truitt","year":"2016","journal-title":"Nat. Rev. Cancer"},{"key":"10.1074\/jbc.TM118.003336_bib59","first-page":"E41","article-title":"Myc, oncogenic protein translation, and the role of polyamines","volume":"6","author":"Flynn","year":"2018","journal-title":"Med. Sci"},{"key":"10.1074\/jbc.TM118.003336_bib60","doi-asserted-by":"crossref","first-page":"9085","DOI":"10.1073\/pnas.0402770101","article-title":"The Fbw7 tumor suppressor regulates glycogen synthase kinase 3 phosphorylation-dependent c-Myc protein degradation","volume":"101","author":"Welcker","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"10.1074\/jbc.TM118.003336_bib61","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1038\/ncb1601","article-title":"The ubiquitin-specific protease USP28 is required for MYC stability","volume":"9","author":"Popov","year":"2007","journal-title":"Nat. Cell Biol"},{"key":"10.1074\/jbc.TM118.003336_bib62","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1038\/nm.4180","article-title":"HAUSP deubiquitinates and stabilizes N-Myc in neuroblastoma","volume":"22","author":"Tavana","year":"2016","journal-title":"Nat. Med"},{"key":"10.1074\/jbc.TM118.003336_bib63","doi-asserted-by":"crossref","first-page":"13726","DOI":"10.1073\/pnas.1610626113","article-title":"Structural basis of N-Myc binding by Aurora-A and its destabilization by kinase inhibitors","volume":"113","author":"Richards","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"10.1074\/jbc.TM118.003336_bib64","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.molcel.2016.09.016","article-title":"Polo-like kinase-1 regulates Myc stabilization and activates a feedforward circuit promoting tumor cell survival","volume":"64","author":"Xiao","year":"2016","journal-title":"Mol. Cell"},{"key":"10.1074\/jbc.TM118.003336_bib65","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.ccr.2013.05.005","article-title":"Small molecule inhibitors of aurora-A induce proteasomal degradation of N-myc in childhood neuroblastoma","volume":"24","author":"Brockmann","year":"2013","journal-title":"Cancer Cell"},{"key":"10.1074\/jbc.TM118.003336_bib66","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.ccell.2016.12.005","article-title":"MYC drives progression of small cell lung cancer to a variant neuroendocrine subtype with vulnerability to Aurora kinase inhibition","volume":"31","author":"Mollaoglu","year":"2017","journal-title":"Cancer Cell"},{"key":"10.1074\/jbc.TM118.003336_bib67","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.ccell.2016.07.002","article-title":"Small molecule inhibitors of Aurora-A induce proteasomal degradation of N-Myc in childhood neuroblastoma","volume":"30","author":"Brockmann","year":"2016","journal-title":"Cancer Cell"},{"key":"10.1074\/jbc.TM118.003336_bib68","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1038\/nm.4107","article-title":"A MYC-Aurora kinase A protein complex represents an actionable drug target in p53-altered liver cancer","volume":"22","author":"Dauch","year":"2016","journal-title":"Nat. Med"},{"key":"10.1074\/jbc.TM118.003336_bib69","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.ccr.2014.07.015","article-title":"Drugging MYCN through an allosteric transition in Aurora kinase A","volume":"26","author":"Gustafson","year":"2014","journal-title":"Cancer Cell"},{"key":"10.1074\/jbc.TM118.003336_bib70","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/leu.2014.222","article-title":"Discovery and development of the Polo-like kinase inhibitor volasertib in cancer therapy","volume":"29","author":"Gjertsen","year":"2015","journal-title":"Leukemia"},{"key":"10.1074\/jbc.TM118.003336_bib71","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1097\/JTO.0b013e3181d95dd4","article-title":"The efficacy and safety of BI 2536, a novel Plk-1 inhibitor, in patients with stage IIIB\/IV non-small cell lung cancer who had relapsed after, or failed, chemotherapy: results from an open-label, randomized phase II clinical trial","volume":"5","author":"Sebastian","year":"2010","journal-title":"J. Thorac. Oncol"},{"key":"10.1074\/jbc.TM118.003336_bib72","doi-asserted-by":"crossref","first-page":"5835","DOI":"10.1158\/1078-0432.CCR-12-3629","article-title":"Molecular pathways: targeting MYC-induced metabolic reprogramming and oncogenic stress in cancer","volume":"19","author":"Li","year":"2013","journal-title":"Clin. Cancer Res"},{"key":"10.1074\/jbc.TM118.003336_bib73","doi-asserted-by":"crossref","first-page":"10258","DOI":"10.1073\/pnas.1222404110","article-title":"MYC inhibition induces metabolic changes leading to accumulation of lipid droplets in tumor cells","volume":"110","author":"Zirath","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"10.1074\/jbc.TM118.003336_bib74","doi-asserted-by":"crossref","first-page":"32380","DOI":"10.18632\/oncotarget.6116","article-title":"Direct inhibition of c-MYC\u2013MAX heterodimers by celastrol and celastrol-inspired triterpenoids","volume":"6","author":"Wang","year":"2015","journal-title":"Oncotarget"},{"key":"10.1074\/jbc.TM118.003336_bib75","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/dju320","article-title":"Therapeutic effects of an anti-Myc drug on mouse pancreatic cancer","volume":"106","author":"Stellas","year":"2014","journal-title":"J. Natl. Cancer Inst"},{"key":"10.1074\/jbc.TM118.003336_bib76","doi-asserted-by":"crossref","first-page":"4234","DOI":"10.1016\/j.bmc.2018.07.019","article-title":"Synthetic molecules for disruption of the MYC protein-protein interface","volume":"26","author":"Jacob","year":"2018","journal-title":"Bioorg. Med. Chem"},{"key":"10.1074\/jbc.TM118.003336_bib77","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1039\/c002534h","article-title":"Small-molecule inhibitors of c-Myc transcriptional factor suppress proliferation and induce apoptosis of promyelocytic leukemia cell via cell cycle arrest","volume":"6","author":"Jeong","year":"2010","journal-title":"Mol. Biosyst"},{"key":"10.1074\/jbc.TM118.003336_bib78","doi-asserted-by":"crossref","first-page":"6653","DOI":"10.1039\/C7CC01705G","article-title":"Specific dsDNA recognition by a mimic of the DNA binding domain of the c-Myc\/Max transcription factor","volume":"53","author":"Ruiz Garcia","year":"2017","journal-title":"Chem. Commun"},{"key":"10.1074\/jbc.TM118.003336_bib79","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1038\/nrd3374","article-title":"Harnessing synthetic lethal interactions in anticancer drug discovery","volume":"10","author":"Chan","year":"2011","journal-title":"Nat. Rev. Drug Discov"},{"key":"10.1074\/jbc.TM118.003336_bib80","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1038\/nrc1691","article-title":"The concept of synthetic lethality in the context of anticancer therapy","volume":"5","author":"Kaelin","year":"2005","journal-title":"Nat. Rev. Cancer"},{"key":"10.1074\/jbc.TM118.003336_bib81","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1038\/nrg.2017.47","article-title":"Synthetic lethality and cancer","volume":"18","author":"O'Neil","year":"2017","journal-title":"Nat. Rev. Genet"},{"key":"10.1074\/jbc.TM118.003336_bib82","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a014209","article-title":"Synthetic lethal screens as a means to understand and treat MYC-driven cancers","volume":"4","author":"Cermelli","year":"2014","journal-title":"Cold Spring Harb. Perspect. Med"},{"key":"10.1074\/jbc.TM118.003336_bib83","doi-asserted-by":"crossref","first-page":"99","DOI":"10.2174\/1568009615666150121162921","article-title":"MYC-mediated synthetic lethality for treating tumors","volume":"15","author":"Li","year":"2015","journal-title":"Curr. Cancer Drug Targets"},{"key":"10.1074\/jbc.TM118.003336_bib84","doi-asserted-by":"crossref","first-page":"53","DOI":"10.2174\/1568009615666150105120055","article-title":"MYC-mediated synthetic lethality for treatment of hematological malignancies","volume":"15","author":"Li","year":"2015","journal-title":"Curr. Cancer Drug Targets"},{"key":"10.1074\/jbc.TM118.003336_bib85","doi-asserted-by":"crossref","first-page":"3336","DOI":"10.1073\/pnas.1012351108","article-title":"RNAi screen of the protein kinome identifies checkpoint kinase 1 (CHK1) as a therapeutic target in neuroblastoma","volume":"108","author":"Cole","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"10.1074\/jbc.TM118.003336_bib86","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.ccell.2016.01.002","article-title":"Exploitation of the apoptosis-primed state of MYCN-amplified neuroblastoma to develop a potent and specific targeted therapy combination","volume":"29","author":"Ham","year":"2016","journal-title":"Cancer Cell"},{"key":"10.1074\/jbc.TM118.003336_bib87","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1038\/nature14985","article-title":"The spliceosome is a therapeutic vulnerability in MYC-driven cancer","volume":"525","author":"Hsu","year":"2015","journal-title":"Nature"},{"key":"10.1074\/jbc.TM118.003336_bib88","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1038\/ncb2004","article-title":"Cdk2 suppresses cellular senescence induced by the c-myc oncogene","volume":"12","author":"Campaner","year":"2010","journal-title":"Nat. Cell Biol"},{"key":"10.1074\/jbc.TM118.003336_bib89","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1073\/pnas.0900121106","article-title":"Phosphorylation by Cdk2 is required for Myc to repress Ras-induced senescence in cotransformation","volume":"107","author":"Hydbring","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"10.1074\/jbc.TM118.003336_bib90","doi-asserted-by":"crossref","first-page":"12968","DOI":"10.1073\/pnas.0901418106","article-title":"Inactivation of CDK2 is synthetically lethal to MYCN over-expressing cancer cells","volume":"106","author":"Molenaar","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"10.1074\/jbc.TM118.003336_bib91","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1006\/bbrc.1994.1990","article-title":"Activation of the proto-oncogene c-myc and c-fos by c-ras: involvement of polyamines","volume":"202","author":"Tabib","year":"1994","journal-title":"Biochem. Biophys. Res. Commun"},{"key":"10.1074\/jbc.TM118.003336_bib92","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1098\/rstl.1677.0068","article-title":"Observationes D. Anthonii Lewenhoeck, de natis e semine genitali aminalculis","volume":"12","author":"Lewenhoeck","year":"1677","journal-title":"Phil. Trans"},{"key":"10.1074\/jbc.TM118.003336_bib93","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.plaphy.2010.02.003","article-title":"The early history of polyamine research","volume":"48","author":"Bachrach","year":"2010","journal-title":"Plant Physiol. Biochem"},{"key":"10.1074\/jbc.TM118.003336_bib94","series-title":"A Guide to the Polyamines","first-page":"512","author":"Cohen","year":"1998"},{"key":"10.1074\/jbc.TM118.003336_bib95","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1146\/annurev.bi.53.070184.003533","article-title":"Polyamines","volume":"53","author":"Tabor","year":"1984","journal-title":"Annu. Rev. Biochem"},{"key":"10.1074\/jbc.TM118.003336_bib96","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1126\/science.127.3302.814.b","article-title":"Presence of polyamines in certain bacterial viruses","volume":"127","author":"Ames","year":"1958","journal-title":"Science"},{"key":"10.1074\/jbc.TM118.003336_bib97","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/0042-6822(57)90061-2","article-title":"Some minor components of bacteriophage T2 particles","volume":"4","author":"Hershey","year":"1957","journal-title":"Virology"},{"key":"10.1074\/jbc.TM118.003336_bib98","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/0022-2836(67)90094-0","article-title":"Complexes between DNA and polyamines: a molecular model","volume":"24","author":"Liquori","year":"1967","journal-title":"J. Mol. Biol"},{"key":"10.1074\/jbc.TM118.003336_bib99","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/0022-2836(69)90049-7","article-title":"An X-ray study of the interaction of DNA with spermine","volume":"42","author":"Suwalsky","year":"1969","journal-title":"J. Mol. Biol"},{"key":"10.1074\/jbc.TM118.003336_bib100","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1016\/S0021-9258(18)69373-1","article-title":"Polyamines and ribosome structure","volume":"235","author":"Cohen","year":"1960","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.TM118.003336_bib101","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1073\/pnas.64.2.669","article-title":"The polyamine content of the tRNA of E. coli","volume":"64","author":"Cohen","year":"1969","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"10.1074\/jbc.TM118.003336_bib102","series-title":"Polyamine Cell Signaling","first-page":"75","author":"Hobbs","year":"2006"},{"key":"10.1074\/jbc.TM118.003336_bib103","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1002\/bies.950150811","article-title":"Polyamines, chromatin structure and transcription","volume":"15","author":"Matthews","year":"1993","journal-title":"Bioessays"},{"key":"10.1074\/jbc.TM118.003336_bib104","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1042\/bj3250289","article-title":"Interactions of polyamines with ion channels","volume":"325","author":"Williams","year":"1997","journal-title":"Biochem. J"},{"key":"10.1074\/jbc.TM118.003336_bib105","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1007\/s00018-003-2332-4","article-title":"Polyamine-dependent gene expression","volume":"60","author":"Childs","year":"2003","journal-title":"Cell. Mol. Life Sci"},{"key":"10.1074\/jbc.TM118.003336_bib106","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/S1357-2725(02)00305-9","article-title":"Transcriptional regulation of the ornithine decarboxylase gene by c-Myc\/Max\/Mad network and retinoblastoma protein interacting with c-Myc","volume":"35","author":"Auvinen","year":"2003","journal-title":"Int. J. Biochem. Cell Biol"},{"key":"10.1074\/jbc.TM118.003336_bib107","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1038\/360355a0","article-title":"Ornithine decarboxylase activity is critical for cell transformation","volume":"360","author":"Auvinen","year":"1992","journal-title":"Nature"},{"key":"10.1074\/jbc.TM118.003336_bib108","doi-asserted-by":"crossref","first-page":"14904","DOI":"10.1074\/jbc.R116.731661","article-title":"Functions of polyamines in mammals","volume":"291","author":"Pegg","year":"2016","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.TM118.003336_bib109","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S1357-2725(98)00135-6","article-title":"Translational regulation of ornithine decarboxylase and other enzymes of the polyamine pathway","volume":"31","author":"Shantz","year":"1999","journal-title":"Int. J. Biochem. Cell Biol"},{"key":"10.1074\/jbc.TM118.003336_bib110","doi-asserted-by":"crossref","DOI":"10.1126\/science.aan2788","article-title":"Spermidine in health and disease","volume":"359","author":"Madeo","year":"2018","journal-title":"Science"},{"key":"10.1074\/jbc.TM118.003336_bib111","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/nrd2243","article-title":"Targeting polyamine metabolism and function in cancer and other hyperproliferative diseases","volume":"6","author":"Casero","year":"2007","journal-title":"Nat. Rev. Drug Discov"},{"key":"10.1074\/jbc.TM118.003336_bib112","doi-asserted-by":"crossref","first-page":"2937","DOI":"10.1042\/BCJ20160383","article-title":"Targeting polyamine metabolism for cancer therapy and prevention","volume":"473","author":"Murray-Stewart","year":"2016","journal-title":"Biochem. J"},{"key":"10.1074\/jbc.TM118.003336_bib113","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1042\/bj20031327","article-title":"A perspective of polyamine metabolism","volume":"376","author":"Wallace","year":"2003","journal-title":"Biochem. J"},{"key":"10.1074\/jbc.TM118.003336_bib114","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1038\/s41568-018-0050-3","article-title":"Polyamine metabolism and cancer: treatments, challenges and opportunities","volume":"18","author":"Casero","year":"2018","journal-title":"Nat. Rev. Cancer"},{"key":"10.1074\/jbc.TM118.003336_bib115","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/0092-8674(95)90450-6","article-title":"Autoregulatory frameshifting in decoding mammalian ornithine decarboxylase antizyme","volume":"80","author":"Matsufuji","year":"1995","journal-title":"Cell"},{"key":"10.1074\/jbc.TM118.003336_bib116","doi-asserted-by":"crossref","first-page":"14529","DOI":"10.1074\/jbc.R500031200","article-title":"Regulation of ornithine decarboxylase","volume":"281","author":"Pegg","year":"2006","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.TM118.003336_bib117","first-page":"2377","article-title":"Degradation of ornithine decarboxylase: exposure of the C-terminal target by a polyamine-inducible inhibitory protein","volume":"13","author":"Li","year":"1993","journal-title":"Mol. Cell. Biol"},{"key":"10.1074\/jbc.TM118.003336_bib118","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1093\/emboj\/cdg158","article-title":"Determinants of proteasome recognition of ornithine decarboxylase, a ubiquitin-independent substrate","volume":"22","author":"Zhang","year":"2003","journal-title":"EMBO J"},{"key":"10.1074\/jbc.TM118.003336_bib119","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S0300-9084(01)01252-4","article-title":"Antizyme, a mediator of ubiquitin-independent proteasomal degradation","volume":"83","author":"Coffino","year":"2001","journal-title":"Biochimie"},{"key":"10.1074\/jbc.TM118.003336_bib120","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1038\/35056508","article-title":"Regulation of cellular polyamines by antizyme","volume":"2","author":"Coffino","year":"2001","journal-title":"Nat. Rev. Mol. Cell Biol"},{"key":"10.1074\/jbc.TM118.003336_bib121","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1080\/15216540500307031","article-title":"The antizyme family: polyamines and beyond","volume":"57","author":"Mangold","year":"2005","journal-title":"IUBMB Life"},{"key":"10.1074\/jbc.TM118.003336_bib122","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1110\/ps.073427208","article-title":"Crystallographic and biochemical studies revealing the structural basis for antizyme inhibitor function","volume":"17","author":"Albeck","year":"2008","journal-title":"Protein Sci"},{"key":"10.1074\/jbc.TM118.003336_bib123","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1007\/s00018-005-5583-4","article-title":"Antizyme inhibitor: mysterious modulator of cell proliferation","volume":"63","author":"Mangold","year":"2006","journal-title":"Cell. Mol. Life Sci"},{"key":"10.1074\/jbc.TM118.003336_bib124","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/nchembio.557","article-title":"A yeast-based screen reveals that sulfasalazine inhibits tetrahydrobiopterin biosynthesis","volume":"7","author":"Chidley","year":"2011","journal-title":"Nat. Chem. Biol"},{"key":"10.1074\/jbc.TM118.003336_bib125","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1002\/mc.2940030204","article-title":"Increased levels of phorbin, c-myc, and ornithine decarboxylase RNAs in human colon cancer","volume":"3","author":"Guillem","year":"1990","journal-title":"Mol. Carcinog"},{"key":"10.1074\/jbc.TM118.003336_bib126","doi-asserted-by":"crossref","first-page":"8689","DOI":"10.1021\/bi00423a027","article-title":"Mitogenic signaling pathways regulating expression of c-myc and ornithine decarboxylase genes in bovine T-lymphocytes","volume":"27","author":"Morris","year":"1988","journal-title":"Biochemistry"},{"key":"10.1074\/jbc.TM118.003336_bib127","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1002\/jcp.1041330323","article-title":"Messenger RNAs coding for enzymes of polyamine biosynthesis are induced during the G0-G1 transition but not during traverse of the normal G1 phase","volume":"133","author":"Stimac","year":"1987","journal-title":"J. Cell Physiol"},{"key":"10.1074\/jbc.TM118.003336_bib128","first-page":"1117","article-title":"Amplification of N-myc and ornithine decarboxylase genes in human neuroblastoma and hydroxyurea-resistant hamster cell lines","volume":"4","author":"Tonin","year":"1989","journal-title":"Oncogene"},{"key":"10.1074\/jbc.TM118.003336_bib129","first-page":"1583","article-title":"Investigation of co-amplification of the candidate genes ornithine decarboxylase, ribonucleotide reductase, syndecan-1 and a DEAD box gene, DDX1, with N-myc in neuroblastoma. United Kingdom Children's Cancer Study Group","volume":"12","author":"George","year":"1996","journal-title":"Oncogene"},{"key":"10.1074\/jbc.TM118.003336_bib130","doi-asserted-by":"crossref","first-page":"4391","DOI":"10.1158\/1078-0432.CCR-15-2539","article-title":"Polyamine antagonist therapies inhibit neuroblastoma initiation and progression","volume":"22","author":"Evageliou","year":"2016","journal-title":"Clin. Cancer Res"},{"key":"10.1074\/jbc.TM118.003336_bib131","doi-asserted-by":"crossref","first-page":"9735","DOI":"10.1158\/0008-5472.CAN-07-6866","article-title":"ODC1 is a critical determinant of MYCN oncogenesis and a therapeutic target in neuroblastoma","volume":"68","author":"Hogarty","year":"2008","journal-title":"Cancer Res"},{"key":"10.1074\/jbc.TM118.003336_bib132","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.ccr.2005.03.036","article-title":"Targeting ornithine decarboxylase in Myc-induced lymphomagenesis prevents tumor formation","volume":"7","author":"Nilsson","year":"2005","journal-title":"Cancer Cell"},{"key":"10.1074\/jbc.TM118.003336_bib133","doi-asserted-by":"crossref","first-page":"6208","DOI":"10.1158\/1078-0432.CCR-09-0592","article-title":"Associations of a polymorphism in the ornithine decarboxylase gene with colorectal cancer survival","volume":"15","author":"Zell","year":"2009","journal-title":"Clin. Cancer Res"},{"key":"10.1074\/jbc.TM118.003336_bib134","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/nrc1014","article-title":"Neuroblastoma: biological insights into a clinical enigma","volume":"3","author":"Brodeur","year":"2003","journal-title":"Nat. Rev. Cancer"},{"key":"10.1074\/jbc.TM118.003336_bib135","first-page":"E65","article-title":"Polyamine biosynthetic pathway as a drug target for osteosarcoma therapy","volume":"6","author":"Weicht","year":"2018","journal-title":"Med. Sci"},{"key":"10.1074\/jbc.TM118.003336_bib136","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0189044","article-title":"Ornithine decarboxylase as a therapeutic target for endometrial cancer","volume":"12","author":"Kim","year":"2017","journal-title":"PLoS ONE"},{"key":"10.1074\/jbc.TM118.003336_bib137","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1158\/0008-5472.CAN-08-2968","article-title":"Targeting ornithine decarboxylase impairs development of MYCN-amplified neuroblastoma","volume":"69","author":"Rounbehler","year":"2009","journal-title":"Cancer Res"},{"key":"10.1074\/jbc.TM118.003336_bib138","first-page":"226","article-title":"Translational development of difluoromethylornithine (DFMO) for the treatment of neuroblastoma","volume":"4","author":"Bassiri","year":"2015","journal-title":"Transl. Pediatr"},{"key":"10.1074\/jbc.TM118.003336_bib139","doi-asserted-by":"crossref","first-page":"5956","DOI":"10.1158\/1078-0432.CCR-08-3213","article-title":"Disrupting polyamine homeostasis as a therapeutic strategy for neuroblastoma","volume":"15","author":"Evageliou","year":"2009","journal-title":"Clin. Cancer Res"},{"key":"10.1074\/jbc.TM118.003336_bib140","doi-asserted-by":"crossref","first-page":"162","DOI":"10.3389\/fonc.2012.00162","article-title":"Polyamine pathway inhibition as a novel therapeutic approach to treating neuroblastoma","volume":"2","author":"Gamble","year":"2012","journal-title":"Front. Oncol"},{"key":"10.1074\/jbc.TM118.003336_bib141","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1038\/nrc1454","article-title":"Polyamines and cancer: old molecules, new understanding","volume":"4","author":"Gerner","year":"2004","journal-title":"Nat. Rev. Cancer"},{"key":"10.1074\/jbc.TM118.003336_bib142","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aar2606","article-title":"Oil for the cancer engine: the cross-talk between oncogenic signaling and polyamine metabolism","volume":"4","author":"Arruabarrena-Aristorena","year":"2018","journal-title":"Sci. Adv"},{"key":"10.1074\/jbc.TM118.003336_bib143","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1517\/14656566.8.13.2109","article-title":"Targeting polyamine metabolism: a viable therapeutic\/preventative solution for cancer?","volume":"8","author":"Wallace","year":"2007","journal-title":"Expert Opin. Pharmacother"},{"key":"10.1074\/jbc.TM118.003336_bib144","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1042\/BST0350353","article-title":"Revival of 2-(difluoromethyl)ornithine (DFMO), an inhibitor of polyamine biosynthesis, as a cancer chemopreventive agent","volume":"35","author":"Raul","year":"2007","journal-title":"Biochem. Soc. Trans"},{"key":"10.1074\/jbc.TM118.003336_bib145","first-page":"1852","article-title":"S-Adenosylmethionine synthetase is overexpressed in murine neuroblastoma cells resistant to nucleoside analogue inhibitors of S-adenosylhomocysteine hydrolase: a novel mechanism of drug resistance","volume":"59","author":"Dwivedi","year":"1999","journal-title":"Cancer Res"},{"key":"10.1074\/jbc.TM118.003336_bib146","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1101\/gad.1067003","article-title":"Genomic targets of the human c-Myc protein","volume":"17","author":"Fernandez","year":"2003","journal-title":"Genes Dev"},{"key":"10.1074\/jbc.TM118.003336_bib147","doi-asserted-by":"crossref","first-page":"2353","DOI":"10.1007\/s00726-016-2275-3","article-title":"Targeting the polyamine-hypusine circuit for the prevention and treatment of cancer","volume":"48","author":"Nakanishi","year":"2016","journal-title":"Amino Acids"},{"issue":"Suppl. 1","key":"10.1074\/jbc.TM118.003336_bib148","doi-asserted-by":"crossref","first-page":"E96","DOI":"10.1002\/mc.22051","article-title":"Polyamines are oncometabolites that regulate the LIN28\/let-7 pathway in colorectal cancer cells","volume":"53","author":"Paz","year":"2014","journal-title":"Mol. Carcinog"},{"key":"10.1074\/jbc.TM118.003336_bib149","doi-asserted-by":"crossref","first-page":"196","DOI":"10.18632\/oncotarget.2768","article-title":"Targeting ornithine decarboxylase reverses the LIN28\/Let-7 axis and inhibits glycolytic metabolism in neuroblastoma","volume":"6","author":"Lozier","year":"2015","journal-title":"Oncotarget"},{"key":"10.1074\/jbc.TM118.003336_bib150","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1038\/ng.2436","article-title":"LIN28B induces neuroblastoma and enhances MYCN levels via let-7 suppression","volume":"44","author":"Molenaar","year":"2012","journal-title":"Nat. Genet"},{"key":"10.1074\/jbc.TM118.003336_bib151","doi-asserted-by":"crossref","first-page":"84140","DOI":"10.18632\/oncotarget.20493","article-title":"A novel polyamine blockade therapy activates an anti-tumor immune response","volume":"8","author":"Alexander","year":"2017","journal-title":"Oncotarget"},{"key":"10.1074\/jbc.TM118.003336_bib152","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.it.2017.01.002","article-title":"MYC: master regulator of immune privilege","volume":"38","author":"Casey","year":"2017","journal-title":"Trends Immunol"},{"key":"10.1074\/jbc.TM118.003336_bib153","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1016\/j.celrep.2014.09.046","article-title":"Expression quantitative trait loci and receptor pharmacology implicate Arg1 and the GABA-A receptor as therapeutic targets in neuroblastoma","volume":"9","author":"Hackett","year":"2014","journal-title":"Cell Rep"},{"key":"10.1074\/jbc.TM118.003336_bib154","doi-asserted-by":"crossref","first-page":"3043","DOI":"10.1158\/0008-5472.CAN-14-3443","article-title":"Neuroblastoma arginase activity creates an immunosuppressive microenvironment that impairs autologous and engineered immunity","volume":"75","author":"Mussai","year":"2015","journal-title":"Cancer Res"},{"key":"10.1074\/jbc.TM118.003336_bib155","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-21189-0","article-title":"Novel ubiquitin-independent nucleolar c-Myc degradation pathway mediated by antizyme 2","volume":"8","author":"Murai","year":"2018","journal-title":"Sci. Rep"},{"key":"10.1074\/jbc.TM118.003336_bib156","doi-asserted-by":"crossref","first-page":"6106","DOI":"10.1074\/jbc.M114.619197","article-title":"Polyamine metabolism is sensitive to glycolysis inhibition in human neuroblastoma cells","volume":"290","author":"Ruiz-P\u00e9rez","year":"2015","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.TM118.003336_bib157","doi-asserted-by":"crossref","first-page":"18782","DOI":"10.1073\/pnas.0810199105","article-title":"Myc regulates a transcriptional program that stimulates mitochondrial glutaminolysis and leads to glutamine addiction","volume":"105","author":"Wise","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"10.1074\/jbc.TM118.003336_bib158","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/j.immuni.2011.09.021","article-title":"The transcription factor Myc controls metabolic reprogramming upon T lymphocyte activation","volume":"35","author":"Wang","year":"2011","journal-title":"Immunity"},{"key":"10.1074\/jbc.TM118.003336_bib159","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1126\/science.123.3191.309","article-title":"On the origin of cancer cells","volume":"123","author":"Warburg","year":"1956","journal-title":"Science"},{"key":"10.1074\/jbc.TM118.003336_bib160","first-page":"319","article-title":"Ueber den Stoffwechsel der Tumoren","volume":"152","author":"Warburg","year":"1924","journal-title":"Biochem. Z"},{"key":"10.1074\/jbc.TM118.003336_bib161","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.cmet.2015.10.007","article-title":"Molecular regulation of circadian rhythms by polyamines","volume":"22","author":"Galluzzi","year":"2015","journal-title":"Cell Metab"},{"key":"10.1074\/jbc.TM118.003336_bib162","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1016\/j.cmet.2015.09.011","article-title":"Circadian clock control by polyamine levels through a mechanism that declines with age","volume":"22","author":"Zwighaft","year":"2015","journal-title":"Cell Metab"},{"key":"10.1074\/jbc.TM118.003336_bib163","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1016\/j.cmet.2015.09.003","article-title":"MYC disrupts the circadian clock and metabolism in cancer cells","volume":"22","author":"Altman","year":"2015","journal-title":"Cell Metab"},{"key":"10.1074\/jbc.TM118.003336_bib164","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1097\/CAD.0b013e32833d1cae","article-title":"Apoptosis induced by the potential chemotherapeutic drug N1,N11-diethylnorspermine in a neuroblastoma cell line","volume":"21","author":"S\u00f6derstjerna","year":"2010","journal-title":"Anticancer Drugs"},{"key":"10.1074\/jbc.TM118.003336_bib165","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1002\/pbc.22797","article-title":"Initial testing (stage 1) of the polyamine analog PG11047 by the pediatric preclinical testing program","volume":"57","author":"Smith","year":"2011","journal-title":"Pediatr. Blood Cancer"},{"key":"10.1074\/jbc.TM118.003336_bib166","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1186\/s13059-015-0694-1","article-title":"Comparison of RNA-seq and microarray-based models for clinical endpoint prediction","volume":"16","author":"Zhang","year":"2015","journal-title":"Genome Biol"},{"key":"10.1074\/jbc.TM118.003336_bib167","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1158\/2159-8290.CD-12-0095","article-title":"The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data","volume":"2","author":"Cerami","year":"2012","journal-title":"Cancer Discov"},{"key":"10.1074\/jbc.TM118.003336_bib168","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.2004088","article-title":"Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal","volume":"6","author":"Gao","year":"2013","journal-title":"Sci. Signal"},{"key":"10.1074\/jbc.TM118.003336_bib169","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S1476-5586(04)80047-2","article-title":"ONCOMINE: a cancer microarray database and integrated data-mining platform","volume":"6","author":"Rhodes","year":"2004","journal-title":"Neoplasia"},{"key":"10.1074\/jbc.TM118.003336_bib170","doi-asserted-by":"crossref","DOI":"10.1002\/ajmg.a.40523","article-title":"Novel de novo pathogenic variant in the ODC1 gene in a girl with developmental delay, alopecia, and dysmorphic features","author":"Bupp","year":"2018","journal-title":"Am. J. Med. Genet. A"}],"container-title":["Journal of Biological Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925820311832?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925820311832?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1074\/jbc.TM118.003336","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,12]],"date-time":"2024-07-12T05:08:26Z","timestamp":1720760906000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021925820311832"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11]]},"references-count":170,"journal-issue":{"issue":"48","published-print":{"date-parts":[[2018,11]]}},"alternative-id":["S0021925820311832"],"URL":"https:\/\/doi.org\/10.1074\/jbc.tm118.003336","relation":{},"ISSN":["0021-9258"],"issn-type":[{"value":"0021-9258","type":"print"}],"subject":[],"published":{"date-parts":[[2018,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Polyamine synthesis as a target of MYC oncogenes","name":"articletitle","label":"Article Title"},{"value":"Journal of Biological Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1074\/jbc.TM118.003336","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Bachmann and Geerts.","name":"copyright","label":"Copyright"}]}}